The AIR042A COVID-19 Status Report has been updated. The report will now identify individuals who have started but not completed their primary COVID-19 vaccination course.
See user guide on how to access the AIR042A report on the AIR site via HPOS.
NSW Health exemption form
From 25 February 2022, the NSW COVID-19 medical contraindication form will no longer be an acceptable form of evidence for exemption from the requirement for mandatory vaccination under the various public health orders. The AIR IM011 form immunisation medical exemption is now the only valid exemption form.
Boosters required for up-to-date status
ATAGI advises that all individuals aged 16 years and over are recommended to receive a COVID-19 vaccine booster dose to maintain an “up-to-date” status. This booster dose is now recommended from 3 months after the last primary dose. This is called the ‘due date’.
Booster – updated advice
ATAGI have updated their recommendations on the use of booster doses of COVID-19 vaccine. What’s changed:
Novavax can be used as a booster in people 18+ years if all other COVID-19 vaccines are unsuitable.
AstraZeneca is no longer recommended as a booster dose for people who received AstraZeneca for the first and second dose. AstraZeneca is now only recommended when mRNA vaccines are contraindicated or if patientdeclinean mRNA vaccine.
Pfizer or Moderna is preferred as booster for people 18+ years.
Only Pfizer should be used as a booster for people aged 16 – 17 years.
All primary care vaccination providers currently registered with CVAS (who are also currently on the VCF) will have already received a registration email with details on how to register to use VCF Connect. The email will have come from CV19.Products@health.gov.au. If you have not received this email, phone 1800 316 375. For more information, see VFC Connect FAQs.
The “Tree of community informed strategies to increase childhood vaccination rates” resource presents practical strategies for health services to improve childhood vaccination rates in communities that may generally support vaccination, but experience socio-economic disadvantage and access barriers to immunisation services. The ‘tree’ may also be used by communities to start a conversation about what makes it difficult or easy to get children vaccinated on time in their community, and advocate for changes.
Updated COVID-19 vaccination resources
Temporary medical exemptions
Updated ATAGI expanded guidance on COVID-19 vaccine temporary medical exemptions – changes include:
Rapid antigen tests (that where possible have been reported to the relevant State or Territory reporting system) are now considered acceptable proof of infection for the purposes of a temporary medical exemption to delay vaccination.
The time frame for temporary deferral of vaccination following SARS-CoV-2 infection has been updated from 6 months to 4 months.
The guidance supports the AIR IM011 form immunisation medical exemption.
Palliative care and/or end-of-life care
Updated COVID-19 vaccination decision guide for people receiving palliative care and/or end-of-life care – changes include:
Information on Nuvaxovid (Novavax) COVID-19 vaccination has been added
Information on COVID-19 vaccine boosters has been updated
Information on Spikevax COVID-19 vaccine (Moderna) in children aged 6-11 years has been added
People with immunocompromise
Updated ATAGI provider guide to COVID-19 vaccination of people with immunocompromise – changes include:
people aged 16 years and older who have received a 3-dose primary course due to severe immunocompromise are recommended to receive a booster (i.e. 4th) dose 3 months or more after their 3rd dose
information on Nuvaxovid COVID-19 Vaccine (Novavax) has been included
people aged 6 to 11 years can now receive Spikevax (Moderna) (half the adult dose)
This guide contains information about the COVID-19 vaccines Comirnaty (Pfizer), Spikevax (Moderna), Vaxzevria (AstraZeneca) and Nuvaxovid (Novavax)
COVID-19 live stream update for GPs
Join the latest COVID-19 vaccine live stream update for GPs. The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
COVID-19 weekly update – 02 JANUARY 2023 COVID-19 cases in the region Please note: From next week the latest COVID-19 information will be included in the Sydney Health Weekly newsletter, rather than separated at the top. We will still provide COVID-19 related information as well as the dedicated COVID-19 latest…
FIVE QUESTIONS is where we ask members of the community to talk about how they stay HEALTHY. Randwick scientist and grandmother Hilda Stender shared this: What exercise did you do yesterday? I’ve had two knee replacements – one four years ago and the other six months ago. As a result,…
Immunisation weekly update – 1 February 2023 Childhood immunisation overdue reports CESPHN is inviting general practices to sign up to receive a regular report extracted on your behalf from the Australian Immunisation Register (AIR) which is specific to your practice. This report contains all children aged 0-5 living in the CESPHN region…
Australian Digital Health Agency (ADHA) digital health webinars Implementing MyHealth Record Policies in your organisation Thu 9 Feb 23, 12.30-1.00 pm – learn how to implement and maintain a My Health Record Security and Access policy in your organisation. Understand the importance of the Responsible Officer (RO) and Organisational Maintenance…
UNSW research – Palliative care and intellectual disability A research team led by Professor Julian Trollor at the Department of Developmental Disability Neuropsychiatry, UNSW Sydney, aims to design, implement, and evaluate a new palliative care service for people with intellectual disability. This is important because people with intellectual disability often…
GP support needed: Shared e-Care plan study for follow-up of colorectal and breast cancers This research evaluates shared care using a new interactive e-care plan being implemented through cancer services in Prince of Wales and St George public and private hospitals. Through the e-care plan GPs, cancer specialists and patients…